L

Lexicon Pharmaceuticals
D

LXRX

0.89000
USD
0.04
(4.83%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
321,728,143
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    AMGN
    4.27
    (1.56%)
    277.86 USD
    AZN
    AZN
    0.405
    (0.59%)
    68.610 USD
    BMY
    BMY
    2.065
    (3.62%)
    59.140 USD
    GILD
    GILD
    -0.110
    (-0.12%)
    92.910 USD
    JNJ
    JNJ
    1.340
    (0.92%)
    146.590 USD
    LLY
    LLY
    12.69
    (1.68%)
    766.55 USD
    MRK
    MRK
    0.950
    (0.99%)
    96.620 USD
    NVO
    NVO
    0.480
    (0.60%)
    81.100 USD
    PFE
    PFE
    0.410
    (1.58%)
    26.425 USD
    REGN
    REGN
    14.51
    (2.13%)
    694.36 USD
    SNY
    SNY
    0.500
    (0.97%)
    52.000 USD
    المزيد
الأخبار
المقالات

العنوان: Lexicon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.